Healthcare -
Biotechnology - NASDAQ - US
$ 0.3874
-1.95 %
$ 66.1 M
Market Cap
-4.84
P/E
XFOR - LONG-TERM DEBT
Long-term Debt XFOR - X4 Pharmaceuticals, Inc.
57.2 M
LAST VALUE
22.81%
2 YEAR CAGR
48.59%
5 YEAR CAGR
0.00%
10 YEAR CAGR